[Search]
[by date] [by subject] [by continent]

2nd International Congress on Phagocytes

University of Pavia , Pavia
September 4-7, 1996

Invited Speakers:

A. ADEREM (USA), M. BAGGIOLINI (CH), F. BOULAY(F),
A. DAL CANTON (I), G. DANIELI (I), C. DINARELLO (USA),
V. FUSTER (USA), C. GABRIELLI (I), J. HARLAN (USA),
A. MANTOVANI (I), A. NOTARIO (I), P. PAOLETTI (I),
J. RAVETCH (USA), G. RlCEVUTI (I), M. RODBELL (USA),
A. ROSEN (USA), F. ROSSI (I), B. SAMUELSSON (S),
A. SEGAL (UK), M. THELEN (CH), A. VERHOEVEN (NL),
P.A. WARD (USA), G. WEISSMANN (USA).

Program:

Scientific sessions and topics

1.Phagocytic cells
2.Cell adhesion molecules
3.Phagocyte function
4.Phagocyte biochemistry
5.Phagocyte receptors
6.Phagocyte and cytokines/BRM
7.Eicosanoid, cytokine antagonists and monoclonal
antibodies as potential therapeutic agents
8.Pharmacology of phagocytes
9.Signal transduction
10.Nutrition and phagocytes
11.Phagocytic diseases (excess, defective function,
congenital, acquired, neoplasia)
12.Antimicrobial mechanisms of phagocytes in
infectious diseases
13.Phagocytes in non infectious diseases
14.Endothelial and tissue damage
15.Fluorescent probes
16.Clinical and therapeutic aspects
17.Current protocols in phagocyte function study
18.Phagocytes and endocrine system
19.Cytometry
20.Inflammation
21.Apoptosis
22.Phagocyte-derived inflammatory mediators
23.Priming of phagocytes
24.The respiratory burst
25.Reperfusion injury
26.Vasculitis and autoimmunity
27.Carcinogenesis
28.Immunodeficiency
29.Chemokines as potential therapeutic targets
30.Anti-inflammation and drugs



Main lectures

Inflammation and anti-Inflammation
G. Weissmann (USA)
Eicosanoids
B. Samuelson (S)
New Molecules of Inflammation
M. Baggiolini (CH)
G Protein
M. Rodbell (USA)
Cytokine antagonists as new Class of
Therapeutics Agents
C. Dinarello (USA)
Microglial cells and neuronal damage
in Alzheimer and related diseases
F. Rossi (I)



The Congress will be divided in four main areas

1.Technical workshop

2.Physiology
The phagocyte system and ontogenicity of
phagocytes. N. Borregaard (DK)
Phagocyte chemoattractant receptors. R.
Boulay (F)
Phagocyte Fc receptors. J. Ravetch (USA)
Signal transduction, P13-kinase and
neutrophfl activation. M. Thelen (CH)
NADPH-oxidase. A. Verhoeven (NL)
Cytoskeleton. A. Aderem (USA)
Rolling and adhesion.
Endothelium. A. Mantovani (I)

3.Pathology
Phagocyte disorders and therapy.
Disorders of oxydative metabolic burst of
phagocyte. A. Segal (UK)
Basophilic cell culture and some phagocytic
cell proteins. R Conti (I)
Inflammatory cytokines of phagocytes. M.
Cassatella (I)
Apoptosis. A. Rosen (USA)
Host tissue damage. G. Ricevuti (I)
Phagocytes and atherosclerosis. V. Fuster
(USA)
Phagocytes and ischemia injury. M.L.
Entman (USA)

4.Clinical aspects
Phagocytes and the kidney. A. Dal Canton
(I)
Phagocytes and tumors. A. Notario (I)
Phagocytes and the lung. P.A. Ward (USA)
The role of reactive oxygen species in the
pathogenesis of systemic sderosis
(scleroderma). G. Danieli, A. Gabrielli (I)
Antiadhesion therapy. J. Harlan (USA)
Cytokine and cytokine inhibitors therapy.
Pharmacologycal control of phagocyte
function. R. Paoletti (I)

Registration :

Congress Team Project
Via D. Sacchi 12
27100 Pavia, Italy.
Tel. international +39.382.22650
Fax international +39.382.33822.





Deadline for Abstracts: April 30, 1996

Email for Requests and Registration: termedpv@ipv36.unipv.it


Posted by: I confirm Host: trudy.systemy.it date: May 22, 96 13:44:53
Generated by meetings and positions 1.0 by Kai Garlipp